Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.9K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac remodeling and arrhythmia in a mouse model of Depdc5 haploinsufficiency.

Epilepsia·2026
Same author

Non-Synaptic Function and Localization of Syntaxin-Binding Protein 1 in a Mouse Model of STXBP1-Related Epileptic Encephalopathy.

Annals of neurology·2026
Same author

Combined ketone body and glutamine supplementation restores aerobic energy production in AGC1-deficient neuronal progenitors.

Cell death & disease·2025
Same author

3D chromatin-based variant-to-gene maps across 57 human cell types reveal the cellular and genetic architecture of autoimmune disease susceptibility.

Genome biology·2025
Same author

Hyperthermic Seizure Susceptibility and Focal Decreases in Parvalbumin-Expressing Cortical Interneurons in a Mouse Model of PCDH19-Clustering Epilepsy.

bioRxiv : the preprint server for biology·2025
Same author

Cortical versus hippocampal network dysfunction in a human brain assembloid model of epilepsy and intellectual disability.

Cell reports·2025

Related Experiment Video

Updated: Apr 17, 2026

Author Spotlight: Advancing Genetic Epilepsy Studies with Multi-Electrode Array-Based Long-Term Electrophysiological Monitoring of Human Brain Assembloids
06:30

Author Spotlight: Advancing Genetic Epilepsy Studies with Multi-Electrode Array-Based Long-Term Electrophysiological Monitoring of Human Brain Assembloids

Published on: September 27, 2024

2.3K

Reprogramming patient-derived cells to study the epilepsies.

Jack M Parent1, Stewart A Anderson2

  • 1Department of Neurology and Neuroscience Graduate Program, University of Michigan Medical Center and VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.

Nature Neuroscience
|February 25, 2015
PubMed
Summary

Induced pluripotent stem cells offer a promising avenue for studying and treating epilepsy by providing patient-derived neural cells. While promising, applying these advanced techniques to epilepsy research is still in its early stages.

More Related Videos

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

5.6K
Lineage-reprogramming of Pericyte-derived Cells of the Adult Human Brain into Induced Neurons
09:36

Lineage-reprogramming of Pericyte-derived Cells of the Adult Human Brain into Induced Neurons

Published on: May 12, 2014

12.8K

Related Experiment Videos

Last Updated: Apr 17, 2026

Author Spotlight: Advancing Genetic Epilepsy Studies with Multi-Electrode Array-Based Long-Term Electrophysiological Monitoring of Human Brain Assembloids
06:30

Author Spotlight: Advancing Genetic Epilepsy Studies with Multi-Electrode Array-Based Long-Term Electrophysiological Monitoring of Human Brain Assembloids

Published on: September 27, 2024

2.3K
In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

5.6K
Lineage-reprogramming of Pericyte-derived Cells of the Adult Human Brain into Induced Neurons
09:36

Lineage-reprogramming of Pericyte-derived Cells of the Adult Human Brain into Induced Neurons

Published on: May 12, 2014

12.8K

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Genetics

Background:

  • Epilepsies and related brain disorders pose challenges for disease modeling and therapy development using traditional human cell methods.
  • Induced pluripotent stem cells (iPSCs) are emerging as a key tool to overcome these limitations by generating patient-specific neural cells.
  • Current research faces hurdles in applying advanced techniques like genome editing and 3D tissue generation to epilepsy.

Purpose of the Study:

  • To review the progress and challenges of using patient-derived cells for epilepsy research and treatment.
  • To highlight the advantages and limitations of iPSC-based approaches in studying neurological disorders.
  • To identify critical future directions for the application of these technologies in epilepsy.

Main Methods:

  • Utilizing induced pluripotent stem cells (iPSCs) to derive patient-specific neural cells.
  • Employing genome-editing technologies to model epilepsy-related genetic mutations.
  • Developing protocols for generating diverse neural cell types and 3D brain organoids.

Main Results:

  • Patient-derived neural cells from iPSCs enable in vitro disease mechanism studies.
  • iPSC technology offers potential for cell-based epilepsy treatments.
  • The application of advanced iPSC and genome-editing techniques to epilepsy is still nascent.

Conclusions:

  • Patient-derived cells, particularly from iPSCs, represent a significant advancement for epilepsy research and potential therapies.
  • Further development is needed to fully realize the potential of these cutting-edge technologies for neurological disorders.
  • Future research should focus on refining protocols and addressing limitations for broader clinical application in epilepsy.